Scientific publishing

scientists-aghast-at-bizarre-ai-rat-with-huge-genitals-in-peer-reviewed-article

Scientists aghast at bizarre AI rat with huge genitals in peer-reviewed article

AI gone wild —

It’s unclear how such egregiously bad images made it through peer-review.

An actual laboratory rat, who is intrigued.

Enlarge / An actual laboratory rat, who is intrigued.

Appall and scorn ripped through scientists’ social media networks Thursday as several egregiously bad AI-generated figures circulated from a peer-reviewed article recently published in a reputable journal. Those figures—which the authors acknowledge in the article’s text were made by Midjourney—are all uninterpretable. They contain gibberish text and, most strikingly, one includes an image of a rat with grotesquely large and bizarre genitals, as well as a text label of “dck.”

AI-generated Figure 1 of the paper. This image is supposed to show spermatogonial stem cells isolated, purified, and cultured from rat testes.

Enlarge / AI-generated Figure 1 of the paper. This image is supposed to show spermatogonial stem cells isolated, purified, and cultured from rat testes.

On Thursday, the publisher of the review article, Frontiers, posted an “expression of concern,” noting that it is aware of concerns regarding the published piece. “An investigation is currently being conducted and this notice will be updated accordingly after the investigation concludes,” the publisher wrote.

The article in question is titled “Cellular functions of spermatogonial stem cells in relation to JAK/STAT signaling pathway,” which was authored by three researchers in China, including the corresponding author Dingjun Hao of Xi’an Honghui Hospital. It was published online Tuesday in the journal Frontiers in Cell and Developmental Biology.

Frontiers did not immediately respond to Ars’ request for comment, but we will update this post with any response.

The first figure in the paper, the one containing the rat, drew immediate attention as scientists began widely sharing it and commenting on it on social media platforms, including Bluesky and the platform formerly known as Twitter. From a distance, the anatomical image is clearly all sorts of wrong. But, looking closer only reveals more flaws, including the labels “dissilced,” Stemm cells,” “iollotte sserotgomar,” and “dck.” Many researchers expressed surprise and dismay that such a blatantly bad AI-generated image could pass through the peer-review system and whatever internal processing is in place at the journal.

Figure 2 is supposed to be a diagram of the JAK-STAT signaling pathway.

Enlarge / Figure 2 is supposed to be a diagram of the JAK-STAT signaling pathway.

But the rat’s package is far from the only problem. Figure 2 is less graphic but equally mangled. While it’s intended to be a diagram of a complex signaling pathway, it instead is a jumbled mess. One scientific integrity expert questioned whether it provide an overly complicated explanation of “how to make a donut with colorful sprinkles.” Like the first image, the diagram is rife with nonsense text and baffling images. Figure 3 is no better, offering a collage of small circular images that are densely annotated with gibberish. The image is supposed to provide visual representations of how the signaling pathway from Figure 2 regulates the biological properties of spermatogonial stem cells.

Some scientists online questioned whether the text was also AI-generated. One user noted that AI detection software determined that it was likely to be AI-generated; however, as Ars has reported previously, such software is unreliable.

Figure 3 is supposed to show the regulation of biological properties of spermatogonial stem cells by JAK/STAT signaling pathway.

Enlarge / Figure 3 is supposed to show the regulation of biological properties of spermatogonial stem cells by JAK/STAT signaling pathway.

The images, while egregious examples, highlight a growing problem in scientific publishing. A scientist’s success relies heavily on their publication record, with a large volume of publications, frequent publishing, and articles appearing in top-tier journals, all of which earn scientists more prestige. The system incentivizes less-than-scrupulous researchers to push through low-quality articles, which, in the era of AI chatbots, could potentially be generated with the help of AI. Researchers worry that the growing use of AI will make published research less trustworthy. As such, research journals have recently set new authorship guidelines for AI-generated text to try to address the problem. But for now, as the Frontiers article shows, there are clearly some gaps.

Scientists aghast at bizarre AI rat with huge genitals in peer-reviewed article Read More »

anti-abortion-group’s-studies-retracted-before-supreme-court-mifepristone-case

Anti-abortion group’s studies retracted before Supreme Court mifepristone case

retracted —

A large number of other, non-retracted studies find mifepristone to be very safe.

Mifepristone (Mifeprex) and misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022.

Enlarge / Mifepristone (Mifeprex) and misoprostol, the two drugs used in a medication abortion, are seen at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022.

Scientific journal publisher Sage has retracted key abortion studies cited by anti-abortion groups in a legal case aiming to revoke regulatory approval of the abortion and miscarriage medication, mifepristone—a case that has reached the US Supreme Court, with a hearing scheduled for March 26.

On Monday, Sage announced the retraction of three studies, all published in the journal Health Services Research and Managerial Epidemiology. All three were led by James Studnicki, who works for The Charlotte Lozier Institute, a research arm of Susan B. Anthony Pro-Life America. The publisher said the retractions were based on various problems related to the studies’ methods, analyses, and presentation, as well as undisclosed conflicts of interest.

Two of the studies were cited by anti-abortion groups in their lawsuit against the Food and Drug Administration (Alliance for Hippocratic Medicine v. FDA), which claimed the regulator’s approval and regulation of mifepristone was unlawful. The two studies were also cited by District Judge Matthew Kacsmaryk in Texas, who issued a preliminary injunction last April to revoke the FDA’s 2000 approval of mifepristone. A conservative panel of judges for the 5th Circuit Court of Appeals in New Orleans partially reversed that ruling months later, but the Supreme Court froze the lower court’s order until the appeals process had concluded.

Mifepristone, considered safe and effective by the FDA and medical experts, is used in over half of abortions in the US.

Criticism

Amid the legal dispute, the now-retracted studies drew immediate criticism from experts, who pointed out flaws. Of the three, the most influential and heavily criticized is the 2021 study titled “A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015” (PDF). The study suggested that up to 35 percent of women on Medicaid who had a medication abortion between 2001 and 2015 visited an emergency department within 30 days afterward. Its main claim was that medication abortions led to a higher rate of emergency department visits than surgical abortions.

Critics noted a number of problems: The study looked at all emergency department visits, not only visits related to abortion. This could capture medical care beyond abortion-related conditions, because people on Medicaid often lack primary care and resort to going to emergency departments for routine care. When the researchers tried to narrow down the visits to just those related to abortion, they included medical codes that were not related to abortion, such as codes for ectopic pregnancy, and they didn’t capture the seriousness of the condition that prompted the visit. Medication abortions can cause bleeding, and women can go to the emergency department if they don’t know what amount of bleeding is normal. The study also counted multiple visits from the same individual patient as multiple visits, likely inflating the numbers. Last, the study did not put the data in context of emergency department use by Medicaid beneficiaries in general over the time period.

In contrast to Studnicki’s study, the American College of Obstetricians and Gynecologists notes that studies looking at tens of thousands of medication abortions have concluded that “Serious side effects occur in less than 1 percent of patients, and major adverse events—significant infection, blood loss, or hospitalization—occur in less than 0.3 percent of patients. The risk of death is almost non-existent.”

Anti-abortion group’s studies retracted before Supreme Court mifepristone case Read More »